Furthermore, tumor-infiltrating cDC1s can produce chemokines such as the CXC chemokine ligand (CXCL) 9 and CXCL10 to attract CD8+ T cells into the tumor microenvironment (TME), representing an essential role of DCs for cancer immunotherapy [22]. The gene discussed is CXCL10; the disease is neoplasm.